BOSTON – The parable of the blind men and the elephant is sometimes applied to whole genome sequencing. But at a lively session on "The Science of Uncertainty in Genomic Medicine" James Evans of the University of North Carolina told his audience that there is also a personal finance rule about elephants that is apt when considering the clinical use of genomic information. Read More
BOSTON – Location, location, location: The idea that one gene equals one protein is long discredited and research into mechanisms including post-translational modification of proteins and the baroque complexities of epigenetic control is advancing understanding of how one gene can generate multiple proteins. Read More
If biopharma companies heed the advice of their patent attorneys, there will be a mad dash to the Patent and Trademark Office (PTO) over the next few weeks as firms rush to file new patents before the reforms of the America Invents Act (AIA) take effect March 16. Read More
Backing up the European approval of Humira (adalimumab) with more data, Abbott spinout AbbVie for the first time offered long-term, patient-reported health outcomes data from the Phase III IMAgINE-1 trial in young people with Crohn's disease, along with favorable results of a caregiver survey. Read More
